Home LiteratureArticle Details
PMID: 6170535 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Sites of action of trifluoperazine in the inhibition of glucose-stimulated insulin release.

Diabetes ·Vol. 30 ·No. 11 ·1981-11-00 ·Pages 960-6

Janjic D, Wollheim CB, Siegel EG, Krausz Y, Sharp GW

Abstract

暂无摘要

MeSH Terms
1-Methyl-3-isobutylxanthine/pharmacology Animals Biological Transport, Active/drug effects Calcium/metabolism Culture Techniques Glucose/pharmacology Insulin/metabolism Insulin Secretion Islets of Langerhans/drug effects,metabolism Kinetics Male Potassium/pharmacology Rats Rats, Inbred Strains Trifluoperazine/pharmacology
Chemicals
Insulin Trifluoperazine Glucose Potassium Calcium 1-Methyl-3-isobutylxanthine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Janjic D
Wollheim C B
Siegel E G
Krausz Y
Sharp G W
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
DOI
10.2337/diab.30.11.960
Published
1981-11-00
Pages
960-6
Language
English
Region
United States
NLM ID
0372763
Subset
IM
External Links
PubMed source DOI: 10.2337/diab.30.11.960 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2